Emerging studies suggest this peptide, a dual stimulator targeting both the gut-brain axis and another hormone, could offer a notable advancement for weight treatment. Preliminary clinical tests have shown considerable reductions in visceral fat , possibly outperforming existing obesity medications . Despite this, further evaluation is necessary to